Singapore, Aug 28 (ANI): Fitch Solutions has forecast real household spending in India to post a growth of 8.9 per cent year-on-year in 2021 following a contraction of 9.3 per cent in household spending estimated over 2020.
Singapore, August 20 (ANI): Fitch Solutions on Friday revised up both 2020 estimate and 2021 forecast for Bhutan's real GDP growth to minus 1.8 per cent and 4 per cent from minus 2.4 per cent and 2.9 per cent previously.
Singapore, August 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (API) business completed an initial public offering (IPO).
Singapore, August 9 (ANI): Fitch Ratings has assigned Azure Power Energy Ltd's (APEL's) proposed five-year partially amortising US-dollar senior secured notes due 2026 an expected rating of BB-plus.
London [UK], Aug 2 (ANI): Global container port congestion has increased port operators' costs and put pressure on their margins, Fitch Ratings has said.
Mumbai (Maharashtra) [India], July 30 (ANI): The proposed transfer of Jubilant Pharma Ltd's (JPL's) active pharmaceutical ingredients (API) business to its parent Jubilant Pharmova Ltd (JPHL) will not affect JPL's ratings, says Fitch Ratings.
Singapore, July 29 (ANI): Fitch Solutions on Thursday revised up again its 2021 price forecast for sugar as prices have remained more supported than it was expecting amid bad weather in Brazil.
Singapore, July 28 (ANI): Rising internet usage, increasing middle class with greater consumer spending power and the youth demographic representing a greater share of the country's population are driving the Indian e-commerce market's ongoing development, Fitch Solutions has said.
Hong Kong, July 27 (ANI): Fitch Ratings has assigned India Cleantech Energy Ltd's (ICEL's) proposed US dollar senior secured notes due 2026 an expected rating of BB-minus.
Hong Kong, July 26 (ANI): Pandemic-induced fiscal responses and economic contractions have led to a sharp rise in public debt among rated sovereigns in the Asia Pacific (APAC) region but there is significant variation between individual sovereigns' performance, according to Fitch Ratings.
Singapore, July 26 (ANI): Jubilant Pharma Ltd (JPL) will continue to maintain good rating headroom as the impact of a recent US Food and Drug Administration import alert for its generic formulations plant in India will be limited, Fitch Ratings has said.